The ?Vector-borne Risks for Europe: Risk assessment and control of West Nile and Chikungunya virus? (VECTORIE) is a small or medium-scale focused research project for the EU FP7-HEALTH-2010-2.3.3-3 call ?Integrated disease-specific research on West Nile Virus infections, Chikungunya and/or Crimean Congo Haemorrhagic Fever?. Between 2011 and 2013, 7 partners from 6 countries participate, and the funding is ~ 2.7 M?. VECTORIE provides for a multidisciplinary approach, combining the expertise of (basic) virology, entomology and advanced vaccinology in pursuit of improved ways to monitor the spread of West Nile virus (WNV) and Chikungunya virus (CHIKV), to diagnose, treat as well as to prevent infections caused by these viruses. VECTORIE is an integrated approach, addressing Europe?s need to prepare for these vector-borne diseases along three main strands: Vector biology, Virulence & Pathogenesis and Vaccination strategies. The Virology group of the Department of Microbiology and Infectious Diseases is a partner of the project with investigations on the virulence markers and of West Nile virus and the antigenic relationships between flaviviruses.
Contact person: Tamás Bakonyi, Petra Forgách, Mónika Somhegyiné Barna
Research Topics Vector-borne Risks for Europe: Risk assessment and control of West Nile and Chikungunya virus (VECTORIE)